Your Messages Inbox (0) 
Your Unread Messages
See AllMost Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Phase I/II study on docetaxel, gemcitabine and prednisone in castrate refractory metastatic prostate cancer
Cancer Chemotherapy and Pharmacology, 11/06/09
Buch–Hansen TZ et al. – The PSA response rate was promising and the toxicity of DGP was manageable; however OS was comparable to results of treatment with single agent docetaxel.
Related Articles
Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/16/09
Relevance Score: 81%
Trends in non-metastatic prostate cancer management in the Northern and Yorkshire region of England, 2000–2006
British Journal of Cancer, 11/13/09
Relevance Score: 80%
Ethanolic Extract of Propolis Augments TRAIL-Induced Apoptotic Death in Prostate Cancer Cells
Evidence-based Complementary and Alternative Medicine, 11/09/09
Relevance Score: 80%
Could mining be protective against prostate cancer? A study and literature review
Occupational and Environmental Medicine, 10/21/09
Relevance Score: 80%
The Grape Component Piceatannol Induces Apoptosis in DU145 Human Prostate Cancer Cells via the Activation of Extrinsic and Intrinsic Pathways
Journal of Medicinal Food, 10/27/09
Relevance Score: 79%
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Salvage treatment with upfront melphalan 100 mg/m2 and consolidation with novel drugs for fulminant progression of multiple myeloma
Annals of Hematology, 11/24/09
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
Journal of Clinical Oncology, 11/24/09
The rationale for mTOR inhibition in epithelial ovarian cancer
Expert Opinion on Investigational Drugs, 11/24/09
Sponsor
Article Search
Sponsor